S&P 500   4,550.58
DOW   35,430.42
QQQ   389.81
How to trade penny stocks: A step-by-step guide
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
These are the top sectors for blue chip growth in 2024
MercadoLibre up 28% as Latin American ecommerce poised for growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
J&J, Gilead, BMS: A look at undervalued dividend payers
The 4 highest-shorted large-cap stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
The JD.com train is getting ready to leave the station again
3 stocking stuffers you can buy for yourself
S&P 500   4,550.58
DOW   35,430.42
QQQ   389.81
How to trade penny stocks: A step-by-step guide
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
These are the top sectors for blue chip growth in 2024
MercadoLibre up 28% as Latin American ecommerce poised for growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
J&J, Gilead, BMS: A look at undervalued dividend payers
The 4 highest-shorted large-cap stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
The JD.com train is getting ready to leave the station again
3 stocking stuffers you can buy for yourself
S&P 500   4,550.58
DOW   35,430.42
QQQ   389.81
How to trade penny stocks: A step-by-step guide
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
These are the top sectors for blue chip growth in 2024
MercadoLibre up 28% as Latin American ecommerce poised for growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
J&J, Gilead, BMS: A look at undervalued dividend payers
The 4 highest-shorted large-cap stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
The JD.com train is getting ready to leave the station again
3 stocking stuffers you can buy for yourself
S&P 500   4,550.58
DOW   35,430.42
QQQ   389.81
How to trade penny stocks: A step-by-step guide
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
These are the top sectors for blue chip growth in 2024
MercadoLibre up 28% as Latin American ecommerce poised for growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
J&J, Gilead, BMS: A look at undervalued dividend payers
The 4 highest-shorted large-cap stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
The JD.com train is getting ready to leave the station again
3 stocking stuffers you can buy for yourself

Auddia Stock Price, News & Analysis (NASDAQ:AUUD)

$0.20
0.00 (0.00%)
(As of 11/29/2023 ET)
Compare
Today's Range
$0.19
$0.21
50-Day Range
$0.18
$0.38
52-Week Range
$0.17
$1.54
Volume
20,334 shs
Average Volume
1.26 million shs
Market Capitalization
$3.99 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

AUUD stock logo

About Auddia Stock (NASDAQ:AUUD)

Auddia Inc., a technology company, develops AI Platform for the audio and podcast markets. The company's flagship product is Faidr, a subscription based mobile application that enables users to listen to various streaming AM/FM radio stations without commercials. It also provides Vodacast, an interactive podcasting platform; and Podcast Hub, a content management system. The company was formerly known as Clip Interactive, LLC and changed its name to Auddia Inc. in November 2019. Auddia Inc. was founded in 2012 and is headquartered in Boulder, Colorado.

AUUD Stock Price History

AUUD Stock News Headlines

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Maxim Group Downgrades Auddia (AUUD)
Auddia to Appeal Nasdaq Delisting Decision
Auddia (AUUD) Earnings Dates & Reports
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Maxim Group Sticks to Their Buy Rating for Auddia (AUUD)
What's Going On With Auddia Stock Today
Auddia Announces Launch of Its faidr 3.0 Mobile App
Why Is Auddia (AUUD) Stock Up 95% Today?
AUDUSD Forecast and News
Auddia (AUUD) Receives a Buy from Maxim Group
See More Headlines
Receive AUUD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Auddia and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/14/2023
Today
11/30/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
3/28/2024

Industry, Sector and Symbol

Industry
Data processing & preparation
Sub-Industry
N/A
Current Symbol
NASDAQ:AUUD
Fax
N/A
Employees
15
Year Founded
N/A

Profitability

Net Income
$-6,900,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$110,000.00
Book Value
$0.12 per share

Miscellaneous

Free Float
17,454,000
Market Cap
$3.99 million
Optionable
Not Optionable
Beta
0.83
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Dr. Jeffrey John Thramann M.D. (Age 58)
    Founder & Executive Chairman
    Comp: $300k
  • Mr. Michael Thomas Lawless (Age 61)
    Interim CFO, CEO, President, Secretary & Director
    Comp: $260k
  • Mr. Peter Shoebridge (Age 59)
    Chief Technology Officer
    Comp: $225k
  • A. Amy
    Senior Account Manager
  • Theo Romeo
    Chief Marketing Officer
  • P. Kristen
    Office Manager & HR Administrator














AUUD Stock Analysis - Frequently Asked Questions

Should I buy or sell Auddia stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Auddia in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" AUUD shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AUUD, but not buy additional shares or sell existing shares.
View AUUD analyst ratings
or view top-rated stocks.

How have AUUD shares performed in 2023?

Auddia's stock was trading at $0.96 at the start of the year. Since then, AUUD shares have decreased by 79.2% and is now trading at $0.20.
View the best growth stocks for 2023 here
.

Are investors shorting Auddia?

Auddia saw a decline in short interest in November. As of November 15th, there was short interest totaling 47,600 shares, a decline of 47.5% from the October 31st total of 90,700 shares. Based on an average daily volume of 215,000 shares, the short-interest ratio is currently 0.2 days. Approximately 0.3% of the company's shares are sold short.
View Auddia's Short Interest
.

When is Auddia's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, March 28th 2024.
View our AUUD earnings forecast
.

How were Auddia's earnings last quarter?

Auddia Inc. (NASDAQ:AUUD) posted its quarterly earnings data on Tuesday, November, 14th. The company reported ($0.11) earnings per share (EPS) for the quarter.

How do I buy shares of Auddia?

Shares of AUUD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:AUUD) was last updated on 11/30/2023 by MarketBeat.com Staff

My Account -